These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38724244)

  • 1. Losartan potassium liquid formulation for paediatric hospital use: development and stability evaluation.
    Corte AC; Gobetti C; Carlos G; de Oliveira Almeida SH; Ayres MV; Steppe M; Garcia CV
    Eur J Hosp Pharm; 2024 May; ():. PubMed ID: 38724244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, Quality by Design-Based Optimization, and Stability Assessment of Oral Liquid Formulations Containing Baclofen for Hospital Use.
    de Saldanha Simon E; Wingert NR; Gobetti C; Primieri GB; Ayres MV; de Almeida SHO; Volpato NM; Steppe M
    AAPS PharmSciTech; 2022 Nov; 23(8):301. PubMed ID: 36385217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules.
    Winiarski AP; Infeld MH; Tscherne R; Bachynsky M; Rucki R; Nagano-Mate K
    J Am Pharm Assoc (2003); 2007; 47(6):747-55. PubMed ID: 18032138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of Metronidazole Suspensions.
    Donnelly RF; Ying J
    Int J Pharm Compd; 2015; 19(3):248-51. PubMed ID: 26714365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Stability Control of Pediatric Oral Tizanidine Hydrochloride Formulations for Hospital Use.
    Gobetti C; Balsan ME; Ayres MV; de Almeida SHO; de Saldanha Simon E; Wingert NR; Oppe TP; Garcia CV
    AAPS PharmSciTech; 2020 Jul; 21(6):210. PubMed ID: 32729029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of an extemporaneous oral liquid aprepitant formulation.
    Dupuis LL; Lingertat-Walsh K; Walker SE
    Support Care Cancer; 2009 Jun; 17(6):701-6. PubMed ID: 19043742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of warfarin sodium flavoured preservative-free oral liquid formulations.
    Schlatter J; Cisternino S
    Eur J Hosp Pharm; 2018 Oct; 25(e2):e98-e101. PubMed ID: 31157077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of nifedipine in two oral suspensions stored at two temperatures.
    Nahata MC; Morosco RS; Willhite EA
    J Am Pharm Assoc (Wash); 2002; 42(6):865-7. PubMed ID: 12482010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extemporaneous sotalol hydrochloride oral solutions for use in paediatric cardiology: formulation and stability study.
    Klovrzová S; Zahálka L; Kříž T; Zahálková O; Matysová L; Šklubalová Z; Horák P
    Eur J Hosp Pharm; 2016 Jan; 23(1):33-37. PubMed ID: 31156811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of Extemporaneously Compounded Domperidone 5 mg/mL Suspension in Oral Mix in Plastic and Glass Bottles and Plastic Syringes.
    Lingertat-Walsh K; Law S; Walker SE
    Can J Hosp Pharm; 2018; 71(3):165-172. PubMed ID: 29955189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of cilazapril in pediatric oral suspensions prepared from commercially available tablet dosage forms.
    Stanisz BJ; Paszun SK; Zalewska A
    Acta Pol Pharm; 2014; 71(4):661-6. PubMed ID: 25272892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate optimization and validation of an analytical methodology by RP-HPLC for the determination of losartan potassium in capsules.
    Bonfilio R; Tarley CR; Pereira GR; Salgado HR; de Araújo MB
    Talanta; 2009 Nov; 80(1):236-41. PubMed ID: 19782220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of an extemporaneously compounded terbutaline sulfate oral liquid.
    Horner RK; Johnson CE
    Am J Hosp Pharm; 1991 Feb; 48(2):293-5. PubMed ID: 2003504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of zonisamide in extemporaneously compounded oral suspensions.
    Abobo CV; Wei B; Liang D
    Am J Health Syst Pharm; 2009 Jun; 66(12):1105-9. PubMed ID: 19498126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Stability of a Compounded Suspension of Torsemide (5 mg/mL) for Oral Administration.
    Adin D; Johnson PR; Kim CH; Nguyenba T; Rosen S
    J Vet Intern Med; 2017 Nov; 31(6):1822-1826. PubMed ID: 28913839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of flucytosine in an extemporaneously compounded oral liquid.
    Wintermeyer SM; Nahata MC
    Am J Health Syst Pharm; 1996 Feb; 53(4):407-9. PubMed ID: 8673661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sucrose, citric buffer and glucose oxidase on the stability of captopril in liquid formulations.
    Liu J; Chan SY; Ho PC
    J Clin Pharm Ther; 1999 Apr; 24(2):145-50. PubMed ID: 10380067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of an ophthalmic formulation of polyhexamethylene biguanide in gamma-sterilized and ethylene oxide sterilized low density polyethylene multidose eyedroppers.
    Bouattour Y; Chennell P; Wasiak M; Jouannet M; Sautou V
    PeerJ; 2018; 6():e4549. PubMed ID: 29682408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure.
    Ma N; Perks W; Law S; Iazzetta J; Walker S
    Int J Pharm Compd; 2020; 24(6):519-527. PubMed ID: 33217743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.